Now is the time for older adults to start thinking about how they will protect their health this winter, especially those ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

MADISON, Wis. - Wisconsin Department of Health Services (DHS) data show only 17% of Wisconsinites have received a flu shot ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

The holidays are fast approaching along with cooler weather and various respiratory illnesses. Here's when to get your ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

“There is nothing more stressful than having a sick baby, especially when it is something potentially serious like RSV,” NSW ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

For a few years, the second seasonal COVID-19 spike has been accompanied by rising cases of seasonal flu and RSV in what ...

The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025. There are two other vaccines ...

The anti-RSV B cells fit that bill, so Scharffenberger set out to create ... This work was funded by the National Institutes ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...